e-learning
resources
London 2016
Tuesday, 06.09.2016
Asthma points to ponder
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Developing integrated mental health and asthma treatment protocol using quality improvement methods
Sophie Jones (London, United Kingdom), Sophie Jones, Dionne Matthew, Kate Lindley Baron-Cohen, Sarah Elkin
Source:
International Congress 2016 – Asthma points to ponder
Session:
Asthma points to ponder
Session type:
Poster Discussion
Number:
3377
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sophie Jones (London, United Kingdom), Sophie Jones, Dionne Matthew, Kate Lindley Baron-Cohen, Sarah Elkin. Developing integrated mental health and asthma treatment protocol using quality improvement methods. Eur Respir J 2016; 48: Suppl. 60, 3377
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
What is important to people with asthma: Maximising research impact?
Source: International Congress 2015 – Any news from the asthma field?
Year: 2015
Dedicated severe asthma services improve healthcare utilisation and quality of life
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
International perspectives on severe asthma: Current and future challenges in patient care
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Priorities for asthma R&D in Europe: A systematic approach
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Implementation of personalized treatment of asthma by improved phenotyping: Critical review of knowledge gaps and unmet research needs by the European asthma research & innovation partnership (EARIP) expert panel
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015
Shifting respiratory care from lungs to patients: The necessity for patient-focused approach
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Asthma management in a specialist setting: Results of a national survey
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
The contribution of an asthma diagnostic consultation service (ADCS) in obtaining an accurate asthma diagnosis for primary care patients
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Impact of educational intervention on inhaler techniques and disease control
Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals
Year: 2013
Evidence of variation to drive quality improvement: The NHS atlas of variation in respiratory healthcare
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
The real world burden of illness in uncontrolled asthma with elevated eosinophils
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
Decision analytic models in COPD/asthma: A critical review of current evidence
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016
Is data quality more important than data quantity in occupational asthma diagnosis from PEF records?
Source: International Congress 2016 – Occupational epidemiology
Year: 2016
The multicomponent nature of difficult asthma
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Asthma severity and medical resource utilisation
Source: Eur Respir J 2004; 23: 723-729
Year: 2004
The impact of the addition of omalizumab on the utilization of healthcare resources by severe persistent asthma patients
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Internet-based self-management in adolescents with asthma: The role of education, monitoring and symptom perception
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Inhalation technique education and its impact in asthma and COPD
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept